Citation Formats
Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. SOYER Et Al. , "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis," AHOS , 2017

SOYER, N. Et Al. 2017. Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis. AHOS .

SOYER, N., TURGUT, M., HAZNEDAROĞLU, İ. C., yılmaz, f., AYDOĞDU, İ., PİR, A., ... Karakuş, V.(2017). Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis . AHOS

SOYER, NUR Et Al. "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis," AHOS, 2017

SOYER, NUR Et Al. "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis." AHOS , 2017

SOYER, N. Et Al. (2017) . "Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis." AHOS .

@conferencepaper{conferencepaper, author={NUR SOYER Et Al. }, title={Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis}, congress name={AHOS}, city={}, country={}, year={2017}}